Records containing: Von Hippel-Lindau Syndrome
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-31NEI Intramural Biorepository for Retinal Diseases
-
CLINICAL_TRIALS study record update · 2025-05-02A Phase II Trial of Pazopanib in Von Hippel-Lindau Syndrome
-
CLINICAL_TRIALS study record update · 2021-02-15An Expanded Access Imaging of Neuroendocrine Tumors Using 68Ga-DOTA-TOC
-
CLINICAL_TRIALS study record update · 2020-07-14A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
-
CLINICAL_TRIALS study record update · 2019-04-02Evaluation of (68)Gallium- DOTATATE PET/CT for Detecting Primary and Metastatic Neuroendocrine Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-07-02Pilot Study of Intravitreal Injection of Ranibizumab (rhuFAB V2) for Advanced Ocular Disease of Von Hippel-Lindau (VHL) Disease
-
CLINICAL_TRIALS study record update · 2017-02-13A Pilot Trial of TKI 258 (Dovitinib) in Von Hippel-Lindau Syndrome
-
CLINICAL_TRIALS study record update · 2011-12-19Pilot Study of Sunitinib Malate for Advanced Ocular Disease of Von Hippel-Lindau Syndrome
-
CLINICAL_TRIALS study record update · 2011-06-30A Phase 2 Study of SU011248 (Sunitinib Malate) in Von Hippel-Lindau Syndrome